Surgery Partners, Inc.
SGRY
$17.07
$0.010.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -182.84% | -433.73% | -32,333.33% | -1,312.61% | -76.68% |
| Total Depreciation and Amortization | 0.13% | 25.06% | 31.41% | 29.21% | 28.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.53% | 39.38% | 73.97% | 73.04% | 29.50% |
| Change in Net Operating Assets | 19.33% | -29.29% | -22.65% | -87.24% | -75.37% |
| Cash from Operations | 12.34% | -9.22% | 2.08% | 2.14% | 5.41% |
| Capital Expenditure | -0.34% | -2.31% | -7.72% | -1.80% | 4.14% |
| Sale of Property, Plant, and Equipment | 2,833.33% | 3,566.67% | -69.43% | -89.92% | -96.12% |
| Cash Acquisitions | 56.51% | 46.13% | -292.12% | -373.50% | -186.32% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.14% | -18.03% | 64.83% | 73.49% | 64.78% |
| Cash from Investing | 46.61% | 42.66% | -102.44% | -116.53% | -81.44% |
| Total Debt Issued | -64.26% | -61.04% | 74.52% | 109.25% | 659.09% |
| Total Debt Repaid | 65.12% | 65.42% | -40.27% | -58.51% | -103.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.79% | -7.11% | -21.71% | -7.84% | 3.02% |
| Cash from Financing | -140.44% | -94.69% | 416.52% | 268.81% | 105.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.58% | 1.39% | 173.13% | 184.60% | -117.49% |